SynthesisEmerging microbes & infections2022

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.

Su-Yeon Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.